Circulating tumor cell isolation, culture, and downstream molecular analysis

Biotechnol Adv. 2018 Jul-Aug;36(4):1063-1078. doi: 10.1016/j.biotechadv.2018.03.007. Epub 2018 Mar 17.

Abstract

Circulating tumor cells (CTCs) are a major contributor of cancer metastases and hold a promising prognostic significance in cancer detection. Performing functional and molecular characterization of CTCs provides an in-depth knowledge about this lethal disease. Researchers are making efforts to design devices and develop assays for enumeration of CTCs with a high capture and detection efficiency from whole blood of cancer patients. The existing and on-going research on CTC isolation methods has revealed cell characteristics which are helpful in cancer monitoring and designing of targeted cancer treatments. In this review paper, a brief summary of existing CTC isolation methods is presented. We also discuss methods of detaching CTC from functionalized surfaces (functional assays/devices) and their further use for ex-vivo culturing that aid in studies regarding molecular properties that encourage metastatic seeding. In the clinical applications section, we discuss a number of cases that CTCs can play a key role for monitoring metastases, drug treatment response, and heterogeneity profiling regarding biomarkers and gene expression studies that bring treatment design further towards personalized medicine.

Keywords: Cell enrichment; Circulating tumor cells (CTCs); Liquid biopsy; Personalized therapies; Point of care.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Separation / methods*
  • Humans
  • Liquid Biopsy
  • Mice
  • Molecular Diagnostic Techniques
  • Neoplastic Cells, Circulating*
  • Point-of-Care Systems
  • Precision Medicine